SEARCH

EVENT

SPCs: protection of active ingredients, new and old

Joel Beevers, Michael Pears and Stephanie Pilkington explore the practical impact of recent CJEU case law in Royalty Pharma and Teva v Gilead on what constitutes ‘protection’ of active ingredients by the basic patent in the context of SPCs; how patent specifications can be optimised for this purpose; and how it can influence patent filing strategies.

EVENT

Protecting innovation in digital health

Digital health brings together and builds on digital telecommunications, data processing and storage technologies to improve patient outcomes. This webinar, presented by Daniel Hudson, provides an overview on overcoming the challenges in protecting intellectual property in this space.

EVENT

The Europas Pathfounder Workshop: Negotiating with VCs

With challenging times set to last for at least the next 18-24 months, including lower valuations, and more cautious investors, how should startups approach negotiating with VCs in what some are calling a "buyer's market"?